Chris Hollis and colleagues' Article1 in The Lancet Psychiatry has many strengths. It
addresses an important clinical question: does methylphenidate treatment for ADHD …

ADHD affects around 5% of children (aged< 18 years) and although the rate of clinical
diagnoses tends to decline in adulthood, about 2· 5% of adults meet the diagnostic criteria. 1 …

As diagnostic rates of attention-deficit hyperactivity disorder (ADHD) increase worldwide, the
most common questions asked by patients are whether to start a medication, which one, and …

For many years, attention-deficit hyperactivity disorder (ADHD) was thought to be a
childhood-onset disorder that has a limited effect on adult psychopathology. However, the …

ADHD is less likely to be diagnosed in females than males, especially in childhood. Females
also typically receive the diagnosis later than males and are less likely to be prescribed …

States that medication with or without behavioral treatment is more effective than either
alone or routine community care for children with attention deficit hyperactivity disorder …

The Polish Ministry of Health reimburses the costs of pharmacotherapy, including drugs
used to treat ADHD, for people younger than 18 years. Currently, reimbursement of …

A 2023 study1 found a significant recent increase in ADHD medication consumption across
64 countries, with notable regional variations. Overall, between 2015 and 2019 …

We thank Samuele Cortese and colleagues for their network metaanalysis1 on medications
for attentiondeficit hyperactivity disorder (ADHD), which aggregated group-level data from …